Resmed RMD
NYSE RMD
$231.52 +3.08 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Resmed (RMD) Cash & Equivalents Growth (3y) (2012 - 2026)

Resmed (RMD) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -7.03%
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -8.46%
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 27.03%
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 86.12%
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -18.20%
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 7.45%
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 7.68%
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn 5.02%

Historic Data

Download Data
DateValue
Jun 30, 2026 86.12%
Mar 31, 2026 93.87%
Dec 31, 2025 77.55%
Sep 30, 2025 88.33%
Jun 30, 2025 64.10%
Mar 31, 2025 66.58%
Dec 31, 2024 38.97%
Sep 30, 2024 15.58%
Jun 30, 2024 -6.89%
Mar 31, 2024 1.04%
Dec 31, 2023 -6.34%
Sep 30, 2023 -20.83%
Jun 30, 2023 -21.05%
Mar 31, 2023 -13.56%
Dec 31, 2022 7.45%
Sep 30, 2022 6.36%
Jun 30, 2022 22.99%
Mar 31, 2022 11.26%
Dec 31, 2021 9.17%
Sep 30, 2021 6.26%